CIK 0001401040 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in Z4 · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -32.8 M | -19.4 M | -13.7 M |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-12 | 4 | 4 | 2026-08-10 |
| 2026-08-11 | S-8 | FORM S-8 | |
| 2026-08-10 | 10-Q | FORM 10-Q | 2026-06-30 |
| 2026-08-10 | 8-K | FORM 8-K items 2.02,9.01 | 2026-08-10 |
| 2026-06-03 | 4 | 4 | 2026-06-01 |
| 2026-06-03 | 4 | 4 | 2026-06-01 |
| 2026-06-03 | 4 | 4 | 2026-06-01 |
| 2026-06-03 | 4 | 4 | 2026-06-01 |
| 2026-06-03 | 4 | 4 | 2026-06-01 |
| 2026-06-03 | 4 | 4 | 2026-06-01 |
| 2026-06-03 | 4 | 4 | 2026-06-01 |
| 2026-06-03 | 4 | 4 | 2026-06-01 |
| 2026-06-03 | 4 | 4 | 2026-06-01 |
| 2026-05-21 | 8-K | FORM 8-K items 5.07 | 2026-05-20 |
| 2026-05-06 | 10-Q | FORM 10-Q | 2026-03-31 |
| 2026-05-06 | 8-K | FORM 8-K items 2.02,9.01 | 2026-05-06 |
| 2026-04-01 | ARS | ARS | 2025-12-31 |
| 2026-04-01 | DEFA14A | FORM DEFA14A | |
| 2026-04-01 | DEF 14A | FORM DEF 14A | 2026-05-20 |
| 2026-03-31 | 8-K | FORM 8-K items 2.02,9.01 | 2026-03-30 |
| 2026-03-30 | 10-K | FORM 10-K | 2025-12-31 |
| 2026-02-17 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-02-17 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-02-06 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-01-06 | 4 | 4 | 2026-01-02 |
Forms on file (last 1,000): 4 153, 8-K 80, 3 23, 10-Q 23, UPLOAD 13, CORRESP 12, SC 13G/A 12, SC 13G 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=DMAC (0.002 USD), /gw/filings/filings?ticker=DMAC&form=8-K, /gw/filings/facts?ticker=DMAC&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange